CN102526540A - Medicinal composition with effect of relieving pain of main and collateral channels - Google Patents

Medicinal composition with effect of relieving pain of main and collateral channels Download PDF

Info

Publication number
CN102526540A
CN102526540A CN2012100753740A CN201210075374A CN102526540A CN 102526540 A CN102526540 A CN 102526540A CN 2012100753740 A CN2012100753740 A CN 2012100753740A CN 201210075374 A CN201210075374 A CN 201210075374A CN 102526540 A CN102526540 A CN 102526540A
Authority
CN
China
Prior art keywords
weight portion
pharmaceutical composition
rhizoma
weight
medicinal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012100753740A
Other languages
Chinese (zh)
Other versions
CN102526540B (en
Inventor
刘金鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210075374 priority Critical patent/CN102526540B/en
Publication of CN102526540A publication Critical patent/CN102526540A/en
Application granted granted Critical
Publication of CN102526540B publication Critical patent/CN102526540B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a medicinal composition with an effect of relieving pain of main and collateral channels. The medicinal composition consists of rehmannia root, phyllostachys congesta rendle, cassia bark, tall gastrodia tuber, safflower, common clubmoss herb, incised notopterygium rhizome and Ningpo yam rhizome. The medicinal composition can be prepared into clinically-acceptable decoction, pills, capsules, tablets, granules, powder, oral liquid, medicinal liquor, emplastrum, ointment, spray, liniment or tinctures by adding auxiliary materials based on the conventional process. The medicinal composition has the effects of promoting blood circulation, removing blood stasis and dredging main and collateral channels, has an obvious effect of treating the pain caused by the main and collateral channels, vasospasm, rheumatism or traumatic injury and the like, can relieve the pain instantly and does not have toxic or side effect.

Description

A kind of pharmaceutical composition with meridians analgesic effect
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition with meridians analgesic effect.
Background technology
Be a kind of common disease symptoms to the pain that causes because of meridians, vasospasm, rheumatism, traumatic injury etc. at present.The people who suffers from this type of disease symptoms is a lot, receives its ailing torment deeply.The medicine of various treatment pain of selling in the market is a lot, but is that Chinese medicine and western medicine combines mostly, and curative effect is not very remarkable, and side effect is also bigger, can only play mitigation, can not treating both the principal and secondary aspects of a disease.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition with meridians analgesic effect.
The present invention realizes through following technical scheme:
The crude drug of pharmaceutical composition of the present invention consists of:
Radix Rehmanniae Preparata 5-15 weight portion Phyllostachys congesta 5-15 weight portion Cortex Cinnamomi 5-15 weight portion
Rhizoma Gastrodiae 5-15 weight portion Flos Carthami 5-15 weight portion Herba Lycopodii 5-15 weight portion
Rhizoma Et Radix Notopterygii 5-15 weight portion Rhizoma Dioscoreae Nipponicae 5-15 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Rehmanniae Preparata 10 weight portion Phyllostachys congestas 10 weight portion Cortex Cinnamomis 10 weight portions
Rhizoma Gastrodiae 10 weight portion Flos Carthamis 10 weight portion Herba Lycopodiis 10 weight portions
Rhizoma Et Radix Notopterygii 10 weight portion Rhizoma Dioscoreae Nipponicae 10 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Rehmanniae Preparata 7 weight portion Phyllostachys congestas 13 weight portion Cortex Cinnamomis 7 weight portions
Rhizoma Gastrodiae 13 weight portion Flos Carthamis 7 weight portion Herba Lycopodiis 13 weight portions
Rhizoma Et Radix Notopterygii 7 weight portion Rhizoma Dioscoreae Nipponicae 13 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Rehmanniae Preparata 13 weight portion Phyllostachys congestas 7 weight portion Cortex Cinnamomis 13 weight portions
Rhizoma Gastrodiae 7 weight portion Flos Carthamis 13 weight portion Herba Lycopodiis 7 weight portions
Rhizoma Et Radix Notopterygii 13 weight portion Rhizoma Dioscoreae Nipponicae 7 weight portions.
Pharmaceutical composition of the present invention adds conventional adjuvant according to common process and processes the decoction of clinical acceptance, pill, capsule, tablet, granule, powder, oral liquid, medicated wine, emplastrum, ointment, spray, liniment or tincture.
Pharmaceutical composition of the present invention has blood circulation promoting and blood stasis dispelling, dredging the meridian, and is remarkable to the pain effect that causes because of meridians, vasospasm, rheumatism or traumatic injury etc., and can the moment pain relieving.Have no side effect.
Following experimental example is used to further specify the present invention, but is not limited to the present invention.
One, experimental example
1, clinical observation
Pain patients 30 examples that medicated wine of the present invention (according to embodiment 1 method preparation) treatment causes because of meridians, vasospasm, rheumatism or traumatic injury etc., male's 15 examples wherein, women's 15 examples.
2, medicament selection
Medicated wine of the present invention (according to the preparation of embodiment 1 method) is treated two courses of treatment (7 days one courses of treatment), painful area is massaged every day 2-3 time with medicated wine of the present invention.
3, diagnostic criteria
Medical history: the pain that causes because of meridians, vasospasm, rheumatism or traumatic injury etc.
Symptom: arthralgia, myalgia, headache, limbs pain etc.Severe pain when movable is met the cold state of an illness and is increased the weight of.
4, criterion of therapeutical effect
" in cure the desease diagnosis criterion of therapeutical effect " with reference to State Administration of Traditional Chinese Medicine 1994 implements drafts as follows:
Recovery from illness: tcm clinical practice symptom, sign disappear or basic the disappearance;
Produce effects: tcm clinical practice symptom, sign obviously change;
Effectively: tcm clinical practice symptom, sign all take a favorable turn;
Invalid: tcm clinical practice symptom, sign all do not have obvious improvement;
5, therapeutic outcome
Treatment number (example) Cure Produce effects Effectively Invalid Total effective rate (%)
30 25 3 2 0 100%
6, conclusion
Above-mentioned 30 routine patients all use medicated wine of the present invention (according to the preparation of embodiment 1 method), and massage sore place 2-3 time with medicated wine every day, treats two courses of treatment (7 days each courses of treatment), and total effective rate reaches 100%.
7, discuss
Radix Rehmanniae Preparata has another name called Radix Rehmanniae Preparata or throws oneself on the ground in the pharmaceutical composition of the present invention, belongs to goatweed, is a kind of first-class Chinese crude drug, has the YIN nourishing of enriching blood effect; Phyllostachys congesta Latin formal name used at school: Cyperus alternifolius, nature and flavor: sweet in the mouth, property is flat, goes into liver, spleen two warps, has the effect of heat clearing away, diuresis, detumescence, detoxifcation; It is fiery supporing yang that Cortex Cinnamomi has benefit, let the fire back to its origin, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow.Warming the spleen and stomach, removing accumulated cold, the effect of promoting blood circulation; Rhizoma Gastrodiae has the endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, the effect of dispelling wind and removing obstruction in the collateral; Flos Carthami has the effect of the latus rectum of invigorating blood circulation, eliminating stasis to stop pain, is used for that amenorrhea, dysmenorrhea, lochia are not all right, lump in the abdomen mass in the abdomen, traumatic injury; Herba Lycopodii Latin formal name used at school: rhizome of Whiteback Greenbrier has expelling wind and cold, dehumidifying detumescence, the effect of relaxing muscles and tendons and activating QI and blood in the collateral.All medicine merging have blood circulation promoting and blood stasis dispelling, dredging the meridian, and are remarkable to the pain effect that causes because of meridians, vasospasm, rheumatism or traumatic injury etc., and can the moment pain relieving.Have no side effect.
Experimental example two, model case
Case 1: high so-and-so, woman, 67 years old.Suffered from trigeminal neuralgia 10 years, migraine is cured every day 2-3 time with medicated wine of the present invention (according to the preparation of embodiment 1 method) massage two courses of treatment (7 days each courses of treatment).
Case 2: Zhu, woman, 16 years old.Suffer from hyperosteogeny, neck is askew, scoliosis can not normally be gone to school, with capsule of the present invention (according to the preparation of embodiment 2 methods) treatment three courses of treatment (7 days each courses of treatment) healing.
Case 3: Lee, man, 42 years old.Suffer from the rheumatic scapulohumeral periarthritis, the right hand can not be lifted with normal crooked by height, and the difficulty of having a meal, pain are unbearably.Cure with ointment of the present invention (according to the preparation of embodiment 3 methods) treatment two courses of treatment (7 days each courses of treatment).
Case 4: high certain, man, 46 years old.Suffer from cervical spondylosis, headache, dizziness influence operate as normal, cure with spray of the present invention (according to the preparation of embodiment 4 methods) treatment three courses of treatment (7 days each courses of treatment).
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1 medicated wine
Radix Rehmanniae Preparata 10g Phyllostachys congesta 10g Cortex Cinnamomi 10g
Rhizoma Gastrodiae 10g Flos Carthami 10g Herba Lycopodii 10g
Rhizoma Et Radix Notopterygii 10g Rhizoma Dioscoreae Nipponicae 10g
Said medicine seals infusion 7 days with the Chinese liquor 10kg room temperature of brew, irritates to spraying use in the bottle.With medicated wine 2-3 massage every day affected part.
Embodiment 2 capsules
Radix Rehmanniae Preparata 7kg Phyllostachys congesta 13kg Cortex Cinnamomi 7kg
Rhizoma Gastrodiae 13kg Flos Carthami 7kg Herba Lycopodii 13kg
Rhizoma Et Radix Notopterygii 7kg Rhizoma Dioscoreae Nipponicae 13kg
Said medicine is added conventional adjuvant according to common process process capsule.
Embodiment 3 ointments
Radix Rehmanniae Preparata 13kg Phyllostachys congesta 7kg Cortex Cinnamomi 13kg
Rhizoma Gastrodiae 7kg Flos Carthami 13kg Herba Lycopodii 7kg
Rhizoma Et Radix Notopterygii 13kg Rhizoma Dioscoreae Nipponicae 7kg
Said medicine is added conventional adjuvant according to common process process ointment.
Embodiment 4 sprays
Radix Rehmanniae Preparata 10kg Phyllostachys congesta 10kg Cortex Cinnamomi 10kg
Rhizoma Gastrodiae 10kg Flos Carthami 10kg Herba Lycopodii 10kg
Rhizoma Et Radix Notopterygii 10kg Rhizoma Dioscoreae Nipponicae 10kg
Said medicine is added conventional adjuvant according to common process process spray.
Embodiment 5 tablets
Radix Rehmanniae Preparata 7kg Phyllostachys congesta 13kg Cortex Cinnamomi 7kg
Rhizoma Gastrodiae 13kg Flos Carthami 7kg Herba Lycopodii 13kg
Rhizoma Et Radix Notopterygii 7kg Rhizoma Dioscoreae Nipponicae 13kg
Said medicine is added conventional adjuvant according to common process process tablet.
Embodiment 6 liniments
Radix Rehmanniae Preparata 13kg Phyllostachys congesta 7kg Cortex Cinnamomi 13kg
Rhizoma Gastrodiae 7kg Flos Carthami 13kg Herba Lycopodii 7kg
Rhizoma Et Radix Notopterygii 13kg Rhizoma Dioscoreae Nipponicae 7kg
Said medicine is added conventional adjuvant according to common process process liniment.

Claims (6)

1. the pharmaceutical composition with meridians analgesic effect is characterized in that, the crude drug of said composition consists of:
Radix Rehmanniae Preparata 5-15 weight portion Phyllostachys congesta 5-15 weight portion Cortex Cinnamomi 5-15 weight portion
Rhizoma Gastrodiae 5-15 weight portion Flos Carthami 5-15 weight portion Herba Lycopodii 5-15 weight portion
Rhizoma Et Radix Notopterygii 5-15 weight portion Rhizoma Dioscoreae Nipponicae 5-15 weight portion.
2. pharmaceutical composition as claimed in claim 1 is characterized in that, the crude drug of this pharmaceutical composition consists of:
Radix Rehmanniae Preparata 10 weight portion Phyllostachys congestas 10 weight portion Cortex Cinnamomis 10 weight portions
Rhizoma Gastrodiae 10 weight portion Flos Carthamis 10 weight portion Herba Lycopodiis 10 weight portions
Rhizoma Et Radix Notopterygii 10 weight portion Rhizoma Dioscoreae Nipponicae 10 weight portions.
3. pharmaceutical composition as claimed in claim 1 is characterized in that, the crude drug of this pharmaceutical composition consists of:
Radix Rehmanniae Preparata 7 weight portion Phyllostachys congestas 13 weight portion Cortex Cinnamomis 7 weight portions
Rhizoma Gastrodiae 13 weight portion Flos Carthamis 7 weight portion Herba Lycopodiis 13 weight portions
Rhizoma Et Radix Notopterygii 7 weight portion Rhizoma Dioscoreae Nipponicae 13 weight portions.
4. pharmaceutical composition as claimed in claim 1 is characterized in that, the crude drug of this pharmaceutical composition consists of:
Radix Rehmanniae Preparata 13 weight portion Phyllostachys congestas 7 weight portion Cortex Cinnamomis 13 weight portions
Rhizoma Gastrodiae 7 weight portion Flos Carthamis 13 weight portion Herba Lycopodiis 7 weight portions
Rhizoma Et Radix Notopterygii 13 weight portion Rhizoma Dioscoreae Nipponicae 7 weight portions.
5. like the described pharmaceutical composition of one of claim 1-4, it is characterized in that this pharmaceutical composition adds conventional adjuvant according to common process and processes the decoction of clinical acceptance, pill, capsule, tablet, granule, powder, oral liquid, medicated wine, emplastrum, ointment, spray, liniment or tincture.
6. has the application in the medicine of meridians analgesic effect like the described pharmaceutical composition of one of claim 1-4 in preparation.
CN 201210075374 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels Expired - Fee Related CN102526540B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210075374 CN102526540B (en) 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210075374 CN102526540B (en) 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels

Publications (2)

Publication Number Publication Date
CN102526540A true CN102526540A (en) 2012-07-04
CN102526540B CN102526540B (en) 2013-10-23

Family

ID=46335360

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210075374 Expired - Fee Related CN102526540B (en) 2012-03-21 2012-03-21 Medicinal composition with effect of relieving pain of main and collateral channels

Country Status (1)

Country Link
CN (1) CN102526540B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1626187A (en) * 2004-08-09 2005-06-15 刘勇成 Medical paste for rheumatism and bone ache
CN101112537A (en) * 2007-08-15 2008-01-30 陈玉龙 Chinese traditional medicine preparations for treating hyperosteogeny disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1626187A (en) * 2004-08-09 2005-06-15 刘勇成 Medical paste for rheumatism and bone ache
CN101112537A (en) * 2007-08-15 2008-01-30 陈玉龙 Chinese traditional medicine preparations for treating hyperosteogeny disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
曹月龙等: "骨关节炎的中药治疗现状", 《中国临床康复》, vol. 10, no. 35, 20 September 2006 (2006-09-20), pages 130 - 134 *

Also Published As

Publication number Publication date
CN102526540B (en) 2013-10-23

Similar Documents

Publication Publication Date Title
CN102178895B (en) Chinese medicine composition for treating orthopedic disorders and preparation method thereof
CN102166277A (en) Waist healing pill
CN102389532B (en) Pharmaceutical composition for treating pains in neck, shoulder, low-back and leg
CN102631512B (en) Traditional Chinese medicine composition for curing chronic colitis
CN104491220A (en) Traditional Chinese medicine composition for treating herpes zoster
CN102145101A (en) Novel traditional Chinese medicine for treating rheumatic lumbocrural pains
CN102488784A (en) Traditional Chinese medicine composition for treating low back pain
CN102125664B (en) Chinese medicinal preparation for treating cervical spondylosis
CN103656525A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN102727773B (en) Traditional Chinese medicinal capsule for treating blood mucoviscidosis
CN106039225A (en) Traditional Chinese medicine preparation for treating acute lumbar muscle sprain
CN102846741B (en) Navel-applied plaster for treating sequelae of hemiplegia and preparation method thereof
CN105687944A (en) Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis
CN102526540B (en) Medicinal composition with effect of relieving pain of main and collateral channels
CN101596263A (en) A kind of medicine for the treatment of fracture and preparation method thereof
CN104887775A (en) Traditional Chinese medicine preparation for treating neonatal scleredema and preparation method therefor
CN103550620B (en) A kind of externally-applied medicinal composition treating rheumatalgia
CN101983676A (en) Medicament for treating gynecological blood stasis and qi stagnation
CN102028810B (en) Traditional Chinese medicine for treating lumbar intervertebral disc protrusion
CN101897764A (en) Chinese medicinal preparation for treating sciatica
CN104189815A (en) Traditional Chinese medicine preparation for treating children bronchial asthma
CN105288528A (en) Medicinal liquor for treating spleen-stomach disharmony
CN102362937B (en) Medicinal composition for treating rheumatic aches and pains
CN104147263A (en) Traditional Chinese medicine for treating neurodermatitis
CN103316321B (en) Colitis treatment spray

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131023

Termination date: 20190321

CF01 Termination of patent right due to non-payment of annual fee